Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Athersys Inc (NQ: ATHX )

2.220 USD +0.070 (+3.26%)
Streaming Delayed Price Updated: 7:11 AM EST, Jan 26, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Athersys Inc

< Previous 1 2 3 4 5 6 7 8 9
...
29 30 Next >
Market Trends Toward New Normal in Crown, Athersys, CSX, Magellan Health, Spectrum Brands, and MGIC Investment — Emerging Consolidated Expectations, Analyst Ratings
In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Crown Holdings, Inc.... 
From GlobeNewswire News Releases
Athersys to Host Third Quarter Financial Results Call
Athersys, Inc. (NASDAQ: ATHX) will release its third quarter 2018 financial results at approximately 4:00 p.m. Eastern Time on Tuesday, November 6th, 2018, and will host a conference call shortly... 
From GlobeNewswire News Releases
Increasing Number of Cancer Cases to Fuel the Global Cancer Immunotherapy Market Growth
FinancialBuzz.com News Commentary 
From PR Newswire
Add Up The Parts: IWN Could Be Worth $147
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Athersys to Present at 2018 Cell & Gene Meeting on the Mesa
Athersys, Inc. (NASDAQ: ATHX) announced today that Gil Van Bokkelen, Chairman and CEO, will present at the annual Cell & Gene Meeting on the Mesa to be held October 3rd-5th in La Jolla, California. 
From GlobeNewswire News Releases
Commit To Purchase Athersys At $2, Earn 30.7% Annualized Using Options
Investors considering a purchase of Athersys Inc (ATHX) shares, but cautious about paying the going market price of $2.02/share, might benefit from considering selling puts among the alternative... 
Tags Stocks
From Market News Video
Recent Analysis Shows Williams Partners, GameStop, Opko Health, Athersys, CSX, and Kratos Defense & Security Solutions Market Influences — Renewed Outlook, Key Drivers of Growth
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Williams Partners L.P.... 
From GlobeNewswire News Releases
Analysts Anticipate 10% Gains Ahead For The Holdings of SPTM
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Athersys Reports Second Quarter 2018 Results
Management to host conference call at 4:30pm EDT today 
From GlobeNewswire News Releases
The Daily Biotech Pulse: FDA Snub For Gemphire, Ligand Earnings, Insmed's Antibiotic Faces FDA Panel
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Stocks hitting 52-week ... 
Tags FLXN FBIO HTGM
From Benzinga
The Growth of Stem Cell Applications are Contributing to the Cell Therapy Processing Market
FinancialBuzz.com News Commentary 
From PR Newswire
Athersys Makes Important Leadership Hire to Carry Out Its Manufacturing Strategy
Company Appoints Greg Liposky, MBA as Senior Vice President of Commercial Manufacturing 
From GlobeNewswire News Releases
Athersys Announces Enrollment of First Patient in Masters-2 Phase 3 Study of Multistem® Treatment for Ischemic Stroke
Athersys, Inc. (NASDAQ: ATHX) announced today that the first patient has been enrolled its Phase 3 study entitled, MultiStem Administration for Stroke Treatment and Enhanced Recovery Study-2... 
From GlobeNewswire News Releases
Biotechnology Companies Involved in Regenerative Medicine
From ACCESSWIRE
Stem Cell Companies Innovating for the Future
From PR Newswire
Rise of Chronic Diseases Leads to Growing Investment in Stem Cell Research
FinancialBuzz.com News Commentary 
From PR Newswire
Athersys to Host Second Quarter Financial Results Call
Athersys, Inc. (NASDAQ:ATHX) will release its second quarter 2018 financial results at approximately 4:00 PM Eastern Time on Tuesday, August 7th, 2018, and will host a conference call shortly... 
From GlobeNewswire News Releases
Analysts Expect 12% Upside For The Holdings of IWO
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
48 Biggest Movers From Yesterday
Gainers Astrotech Corporation (NASDAQ: ASTC) shares surged 217.44 percent to close at $6.1901 on Tuesday after the ... 
Tags ZKIN COCP PAGS
From Benzinga
23 Stocks Moving In Thursday's Pre-Market Session
Gainers Teligent, Inc. (NASDAQ: TLGT) shares rose 21.4 percent to $3.97 in pre-market trading following the FDA approval of ... 
Tags #PreMarket Gainers TLRD APTO
From Benzinga
44 Biggest Movers From Yesterday
Gainers Nano Dimension Ltd. (NASDAQ: NNDM) shares climbed 101.41 percent to close at $2.68 on Monday. The additive ... 
Tags NTLA GEVO HMI
From Benzinga
32 Stocks Moving In Monday's Mid-Day Session
Gainers Nano Dimension Ltd. (NASDAQ: NNDM) shares jumped 132.1 percent to $3.11 in pre-market trading. The additive ... 
Tags SYK PFIE GNW
From Benzinga
Monday Sector Laggards: Biotechnology, General Contractors & Builders
In trading on Monday, biotechnology shares were relative laggards, down on the day by about 0.4%. Helping drag down the group were shares of TapImmune, down about 8.4% and shares of Athersys off about... 
Tags Stocks
From Market News Video
Innovative Biotech Companies Pushing the Envelope
From PR Newswire
36 Stocks Moving In Thursday's Mid-Day Session
Gainers Top Ships Inc. (NASDAQ: TOPS) shares climbed 78.6 percent to $1.3751 after the company reported a time charter with ... 
Tags VBLT Market News AXON
From Benzinga
Benzinga Pro's 5 Stocks To Watch Today
Each day, the Benzinga Pro news team highlights several stocks with Trading Idea potential. Be the first to see them by becoming a ... 
Tags REVG News Pre/Market Outlook
From Benzinga
27 Stocks Moving In Thursday's Pre-Market Session
Gainers AV Homes, Inc. (NASDAQ: AVHI) shares rose 24.2 percent to $20.50 in pre-market trading after Taylor Morrison Home ... 
Tags AVHI ABM ICPT
From Benzinga
Athersys Announces Expansion of Collaboration With Healios
Athersys, Inc. (NASDAQ:ATHX) announced today that it has entered into an agreement with HEALIOS K.K. (“Healios”) to expand their collaboration into additional therapeutic areas. Under the terms of the... 
From GlobeNewswire News Releases
Benzinga's Daily Biotech Pulse: Vascular Biogenics Soars On Positive Platform Data, Axovant Licenses Parkinson's Candidate
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Stocks hitting 52-week ... 
Tags DCPH INGN Biotech
From Benzinga
Benzinga's Daily Biotech Pulse: Mylan's Neulasta Biosimilar Approved, Portola's CEO To Retire, Regenxbio To Join S&P SmallCap Index
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Stocks hitting 52-week ... 
Tags SCPH VSTM ABMD
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
29 30 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.